EPISODE · Sep 23, 2019 · 23 MIN
The Purdue Pharma Bankruptcy Case: What’s at Stake
from Knowledge at Wharton
Purdue Pharma has been accused of fueling the opioid epidemic with overly aggressive marketing practices for its OxyContin brand. What would a proposed settlement mean for the company and for opioid victims? Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
The Purdue Pharma Bankruptcy Case: What’s at Stake
0:00
23:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Knowledge at Wharton?
This episode is 23 minutes long.
When was this Knowledge at Wharton episode published?
This episode was published on September 23, 2019.
Can I download this Knowledge at Wharton episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!